DA32 Life Science Tech Acquisition Corp. (DALS)

NASDAQ: DALS · IEX Real-Time Price · USD
+0.01 (0.10%)
Jun 24, 2022 1:52 PM EDT - Market closed
Market Cap 248.04M
Revenue (ttm) n/a
Net Income (ttm) -571,294
Shares Out 25.65M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,200
Open 9.67
Previous Close 9.66
Day's Range 9.67 - 9.67
52-Week Range 9.58 - 10.26
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About DALS

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York. [Read more...]

Industry Blank Check / SPAC
IPO Date Jul 28, 2021
Employees 2,021
Stock Exchange NASDAQ
Ticker Symbol DALS
Full Company Profile


DA32 Life Science Tech Acquisition Corp., Sponsored by Deerfield, Arch Venture Partners and Section 32, Announces Pri...

NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 shares of Class A common stock at a price of ...